- B2B
- Scale StageRapidly increasing operations
- Valuation $1B+This company has a valuation of $1B or more
- 4.1Highly ratedPivot Bio is highly rated on Glassdoor, with 4.1 out of 5 stars
- 4.9Work / Life BalanceEmployees rate Pivot Bio 4.9/5 on Glassdoor for work / life balance
- 4.1Strong LeadershipEmployees rate Pivot Bio 4.1/5 on Glassdoor for faith in leadership
Pivot Bio Funding
$86.7M
33 rounds
Pivot Bio is active in the following markets / industries: biotechnology, agriculture and adtech. The company has secured funding across 3 rounds, totaling in an amount of $86.7M. Their most recent funding was raised on October 2, 2018.
Funding Rounds
B
$70000000A
$15996489S
$750000SeedOct 2014
Investors of Pivot Bio
Bayer Crop Science
Multinational agrochemicals and agricultural biotechnology corporation
Rounds
S
DCVC
Rounds
A
Ryan Rakestraw is an Associate Director at Temasek focused on early-stage investments in Food and Agriculture
Managing Director at DCVC Bio- investing in computationally advantaged companies in agriculture, food, biotechnology and therapeutics
Data Collective
Investing in entrepreneurs building deep tech companies